Eunice Wang, MD, Roswell Park Comprehensive Cancer Center

Articles by Eunice Wang, MD, Roswell Park Comprehensive Cancer Center

Role of Molecular Testing in AML

ByHarry P. Erba, MD, PhD, Duke University School of Medicine,Alexander E. Perl, MD, University of Pennsylvania,Eunice Wang, MD, Roswell Park Comprehensive Cancer Center,Adam Bagg, MD, University of Pennsylvania,Corey S. Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute

January 15th 2021

Trending on OncLive

FDA Approves Iberdomide Plus Daratumumab/Dexamethasone for R/R Myeloma

Dive into the Data Supporting the FDA Approval of Iberdomide Plus Daratumumab/Dexamethasone in R/R Myeloma

Five Under 5: Top Oncology Videos for the Week of 8/9

Zipalertinib Plus Chemotherapy Improves PFS in First-Line EGFR Exon 20 Insertion+ NSCLC

FDA Grants Fast Track Designation to Spevatamig in Advanced and Metastatic Biliary Tract Carcinoma